Tissue Regenix comments on study

Tissue Regenix Plc of the UK said that a preclinical study of its tissue regeneration technology showed a better performance than a competitor bovine-derived matrix. The study results were published in the open-access journal, PLoS.
 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom